Everything REMS Under The Sun: FDA Lays Out Ambitious PDUFA V Meeting Agenda
This article was originally published in The Pink Sheet Daily
Executive Summary
The struggles that industry and FDA face when trying to best standardize and evaluate REMS are illustrated by the dozens of topics jammed into the two-day meeting.